Congressman Leonard Lance (NJ-07) today hailed passage of H.R. 6, the 21st Century Cures Act, landmark legislation to modernize our health care system, encourage innovation, support research and streamline drug and device approval.
“Millions of Americans await the genius of 21st Century innovation that is being slowed by a regulatory rules from the last century,” said Lance, a member of the House Energy and Commerce Committee tasked with crafting the legislation. “The 21st Century Cures legislation will open the path to new medicines, improving the quality of life for millions of Americans and enhancing our Nation’s role as the global leader in research and development of the cures for tomorrow.”
The 21st Century Cures Act (H.R. 6) invests in medical research, promotes innovation and modernizes our federal regulatory system to help expedite the discovery, development, and delivery of new cures and provide patients access to safe and effective medicines sooner. The bill also advances important reforms that will help create jobs, boost U.S. competitiveness and save taxpayers billions over the long-term.
The House-passed legislation also includes language co-authored by Lance and Rep. Anna Eshoo (CA-18) exempting future Food and Drug Administration user fees from sequestration. Congressman Lance said that this provision is critical to ensure the FDA is able to fulfill its public health mission by fostering timely patient access to safe and effective new medicines and advancing ground-breaking cures and treatments.
“More than a year and a half ago, the House Energy and Commerce Committee launched the 21st Century Cures initiative to improve comprehensively the way we research and develop medicines to treat diseases, especially those for which there is no cure. And in working closely with researchers, patients, physicians, innovators, advocates and survivors and their families Congress has passed bipartisan legislation that will help bring our country’s health care infrastructure into the 21st Century so that more people can get access to life-saving medicines. This is how the American people expect Congress to work,” concluded Lance.
What others are saying about the 21st Century Cures legislation:
Netcong resident Tammy Quasius, New Jersey District Activist Leader with the National Multiple Sclerosis Societypraised the legislation. “Thank you Congressman Lance for your leadership in passing H.R.6, the 21st Century Cures Act, which offers exciting promise to over 400,000 Americans living with multiple sclerosis. It implements reforms and secures funding levels which will expedite the speed of research and the development process for disease treatments, and establishes a data collection system that will help researchers better understand the incidence and prevalence of multiple sclerosis. Having lived with multiple sclerosis for 11 years now, the passage of this bill would bring me much optimism for a world without MS, erasing the uncertainty in my own future and giving me hope that my two sons will never have to hear the words ‘you have multiple sclerosis.’”
Lisa Schill, New Jersey resident and Vice President of RASopathies Network U.S.A, a rare disease advocacy network, added, “We at the RASopathies Network U.S.A.—as well as the other millions of Americans affected by rare disease—would like to thank Congressman Lance, along with Congressman Upton, Congresswoman DeGette, and the House leadership, for their tireless, bipartisan championship of H.R. 6, the 21st Century Cures Bill. This bill provides us with more than hope. It will promote promising new therapies through innovative research programs, increased funding, and streamlined drug development processes. Truly, it is a roadmap for success in the fight against rare disease—and in the advancement of American health”
Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ) also praised Lance and H.R. 6. “We commend Congressman Lance for his leadership on the 21st Century Cures Act and his sustained advocacy for the patient community. We applaud the U.S. House of Representatives’ passage of this vitally important legislation, which is critical to New Jersey’s life sciences ecosystem and to patients around the world. The 21st Century Cures Act would modernize America’s apparatus for researching, reviewing and approving new life-saving medical therapies, technologies and devices, and would accelerate the pace of discovering cures for some of the world’s most dreaded diseases. We are grateful to Congressman Lance for his role in this victory for patients who need new, life-saving medical breakthroughs to be reviewed, approved and delivered to patients as quickly, efficiently and safely as possible.”
Debbie Hart, President of BioNJ also said that patients cannot wait. “Today’s passage of the 21st Century Cures Act is a huge milestone in creating a new pathway to breakthrough therapies and cures. We recognize and thank those who rallied for this bipartisan legislation that calls for increased NIH funding, encourages greater innovation and streamlines the process to deliver better, faster cures to more Patients. Because, as we say at BioNJ, Patients Can’t Wait.”